Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis Driving Market Growth

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.1%. The surge during the historical period can be credited to factors such as epidemiology, patient awareness and education as well as the development and accessibility of healthcare infrastructure.

Psoriasis Market Size Forecast: What's the Projected Valuation by 2029?
Anticipated robust expansion is on the horizon for the psoriasis market in the upcoming years. The market is projected to escalate to a substantial $42.34 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. This predicted expansion during the forecast timeframe is due to factors like regulatory approvals, preferences of patients, an aging demographic, heightened awareness, and the unveiling of innovative therapies. Key trends expected to arise during this period encompass progress in research and development, biologics and targeted therapies, oral therapies involving small molecules, custom-tailored medicine, digital health and telemedicine, care that is centered on the patient, biosimilars, and the utilization of artificial intelligence and machine learning.

View the full report here:
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

What Are the Drivers Transforming the Psoriasis Market?
The Psoriasis market is getting a major boost from the increasing number of psoriasis patients. This skin disorder results from immunity issues, genetics, and environmental elements. Over the past few years, factors like climate changes, stress, and unhealthy lifestyles have led to a dramatic increase in psoriasis patients. Based on the data from the World Psoriasis Day consortium, psoriasis affects 125 million people around the world, accounting for 2 to 3% of the overall population. As such, the escalating cases of psoriasis are projected to enhance the expansion of the psoriasis market over the forecasted timeframe.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

What Long-Term Trends Will Define the Future of the Psoriasis Market?
Combining treatments is a developing approach within the psoriasis market. This combinatory treatment method involves employing two distinct psoriasis treatments simultaneously. The potency of using two drugs with different functional mechanisms (combinatory therapy) surpasses that of monotherapy, that uses only a single drug. Research indicates that combinatory therapy alleviates psoriasis symptoms more efficiently than sole therapy and offers fewer side effects. A prime illustration of combinatory therapy targeting active psoriatic arthritis (PsA) is the combination of Taltz (ixekizumab) and methotrexate, a product of Eli Lilly and Company.

Which Segments in the Psoriasis Market Offer the Most Profit Potential?
The psoriasis market covered in this report is segmented -

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor
2) By Drug Types: Small molecules, Biologics
3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis
4) By Route Of Administration: Oral, Tropical, Injectable
5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Subsegments:
1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)
2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)
3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast)
4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp

Which Firms Dominate the Psoriasis Market by Market Share and Revenue in 2025?
Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy's Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy

Which Regions Offer the Highest Growth Potential in the Psoriasis Market?
North America was the largest region in the psoriasis market in 2023. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2414

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.